Cargando…
Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma
BACKGROUND: Systemic inflammatory response can be associated with the prognosis of diffuse large B cell lymphoma (DLBCL). We investigated the systemic factors significantly related to clinical outcome in relapsed/refractory DLBCL. METHODS: In 242 patients with DLBCL, several factors, including infla...
Autores principales: | Kim, Do-Young, Song, Moo-Kon, Chung, Joo-Seop, Shin, Ho-Jin, Yang, Deok Hwan, Lim, Sung-Nam, Oh, Sung-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942137/ https://www.ncbi.nlm.nih.gov/pubmed/31915650 http://dx.doi.org/10.5045/br.2019.54.4.244 |
Ejemplares similares
-
Maximum standardized uptake value on positron emission tomography/computed tomography predicts clinical outcome in patients with relapsed or refractory diffuse large B-cell lymphoma
por: Jang, Hee Ryeong, et al.
Publicado: (2015) -
Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
por: Kim, Do Young, et al.
Publicado: (2022) -
Clinical impact of lymphatic spread in patients with limited-stage upper aerodigestive tract NK/T cell lymphoma
por: Song, Moo-Kon, et al.
Publicado: (2021) -
Management of relapsed-refractory diffuse large B cell lymphoma
por: Raut, Lalit S., et al.
Publicado: (2014) -
Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma
por: Oh, Min-Young, et al.
Publicado: (2012)